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Thoracic endovascular aortic repair (TEVAR) is increasingly used in the treatment of 
acute type B aortic dissection. Type Ia endoleaks are a common complication of the 
procedure, but its clinical significance and the best treatment strategy remain poorly 
defined. We present a case of a type Ia endoleak following TEVAR in the treatment of 
acute type B aortic dissection. Chimney technique approach was used in an attempt to 
seal the endoleak. Although technical success was suboptimal, the patient remained 
clinically stable and event free. Data regarding the natural course and management of 
type Ia endoleaks following TEVAR for aortic dissection are sparse. Future research is 
required to establish the clinical and technical determinants of the need to treat these 
endoleaks and the best treatment strategy.
Keywords: endovascular aortic repair, aortic dissection, endovascular intervention, vascular complications, 
endoleak
INtRoDUCtIoN
Aortic dissection has one of the highest mortality rates of cardiovascular diseases, and its manage-
ment remains a challenge. Acute complicated type B aortic dissection may present with signs of 
organ malperfusion, uncontrolled hypertension, or signs of impending rupture such as an increase 
in periaortic hematoma and hemorrhagic pleural effusion in two subsequent computed tomography 
(CT) examinations. Thoracic endovascular aortic repair (TEVAR) has shown a survival benefit when 
compared with open surgery and should be considered as first-line treatment of acute type B aortic 
dissection (1). Type Ia endoleak is a possible complication of TEVAR and is due to an inadequate 
seal at the proximal end of the endograft (2). Type Ia endoleaks immediately following TEVAR in 
patients with type B aortic dissection are relatively common, and their immediate appearance can be 
an indication of worse aortic condition (3). Chimney technique represents a viable treatment option 
in patients with challenging aortic arch pathology by prolonging the proximal landing zone while 
maintaining aortic side branches perfusion (4).
BaCKGRoUND
Clinical History
A 65-year-old man, with history of uncontrolled hypertension, presented at our Center with acute 
thoracic and back pain. AngioCT revealed an acute Stanford type B aortic dissection, extending 
from the proximal descending thoracic aorta (distal to the origin of the left subclavian artery) to the 
iliac arteries (Figure 1). Aortic sizing was performed using CT, and aortic diameter proximal to the 
FIGURe 3 | angioCt showing the increase in type Ia endoleak dimension (arrows).
FIGURe 2 | angioCt showing type Ia endoleak after the teVaR 
procedure.
FIGURe 1 | angioCt showing stanford type B aortic dissection.
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origin of the left subclavian artery was 41 mm. Medical therapy 
in order to control blood pressure was optimized. Despite four 
different classes of antihypertensive drugs, including a diuretic, at 
maximal tolerated doses, blood pressure values were persistently 
high. Thus, a case of an acute complicated (refractory hyperten-
sion) type B aortic dissection was presented and discussed by the 
Heart Team (including General and Interventional Cardiologists, 
Cardiothoracic Surgeons, Anesthesiologists, and experts in 
Cardiovascular Imaging), and a TEVAR was considered to be in 
the best interest of this patient. Implantation of an aortic pros-
thesis (Valiant® Captivia® 42 mm × 150 mm) with planned left 
subclavian artery coverage in order to cover the primary entry tear 
in the proximal thoracic descending aorta was performed. After 
the procedure, the patient was asymptomatic. AngioCT after the 
procedure showed occlusion of the left subclavian artery and an 
endoleak at the proximal graft attachment site – type Ia endoleak 
(Figure 2). The patient was discharged with optimized antihyper-
tensive drug therapy and remained under close follow-up.
Follow-up
A year later, the patient complained about lower back pain. 
AngioTC showed persistency of the aortic dissection to the iliac 
arteries and no increase in the size of the type Ia endoleak. Since 
the recurrence of symptoms is one of the signs of instability in 
the chronic phase of aortic dissection, we decided to perform 
a second TEVAR, placing an aortic endoprosthesis (Valiant® 
46 mm × 150 mm) at the level of the descending aortic, partially 
covering the distal part of the first endoprosthesis.
The patient remained clinically stable, and clinical and imagio-
logical follow-up was performed.
Two years after the first procedure, the patient complained 
about thoracic discomfort. AngioCT showed an increase in 
endoleak dimension at the level of the transition between the 
aortic arch and the proximal descending aorta (Figure 3).
The case was re-evaluated by the Heart Team, and we decided 
to treat the endoleak. In order to do so, we faced the need of 
maintaining perfusion in the supra-aortic branches. Several 
treatment options were discussed: placement of a coil at the site 
of the endoleak would be a less complex procedure, but the entry 
site was subject to high flow pressure, and it was considered not 
to be the best option; a fenestrated prosthesis could resolve the 
FIGURe 4 | Final position of the prosthesis. White arrows:  
self-expandable stents at the brachiocephalic trunk and left common carotid 
artery, placed between aortic wall and aortic endoprosthesis. Black arrow: 
proximal entry site of the endoleak. Arrow head: proximal landing zone of the 
aortic endoprosthesis.
FIGURe 5 | angioCt at 1 month (a), 3 months (B), and 7 months follow-up (C).
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problem of the side branches perfusion, but the prosthesis was 
not readily available, and it would take up to several weeks in 
order to achieve it; and a surgical approach was considered to be 
of high risk.
Taking this into account and based on our previous experi-
ence with the Chimney technique, we decided do use this 
approach. A detailed CT review and evaluation of the aortic arch 
and supra-aortic branches configuration and dimension was 
undertaken. Proximal landing zone of the endoprosthesis was set 
proximal to the origin of the brachiocephalic trunk (dimension 
43 mm × 47 mm), covering the brachiocephalic trunk and left 
common carotid artery, which would be then perfused by deploy-
ment of self-expandable stents, placed between the endoprosthe-
sis and the aortic wall (Figure 4).
Surgical access to the left common carotid artery and percuta-
neous access through right axillary artery to the brachiocephalic 
trunk and through the left femoral artery to the aorta were planned. 
After placement of the guidewires into the supra-aortic branches, 
a third aortic endoprosthesis (GORE®TAG® 45 mm × 150 mm) 
was placed at the level of the aortic arch, proximal to the first one 
and covering the aortic branches, in order to seal the endoleak. 
To ensure the patency of the side branches, self-expandable stents 
(GORE®VIABAHN®) were deployed in the brachiocephalic 
trunk and the left common carotid artery (in Supplementary 
Material Video 1). Despite the attempted correction, the type Ia 
endoleak persisted, with only a small decrease in its dimension 
(in Supplementary Material Video 2). The flow at the vertebral 
artery was evaluated by CT before and after the procedure, and 
no abnormalities were found.
Previous to the intervention, the patient was on single antiplatelet 
therapy (aspirin 150 mg daily), an ACE-inhibitor, a beta-blocker, a 
calcium channel blocker, a diuretic, and a statin. After the interven-
tion, dual antiplatelet therapy was initiated (aspirin 150 mg daily 
plus clopidogrel 75 mg daily) and the remaining therapy maintained.
The patient remained asymptomatic. AngioCT at 1, 3, and 
7  months follow-up (Figures  5A–C, respectively) confirmed 
patency of the stents and the persistency of the endoleak, with no 
increase in its dimension.
DIsCUssIoN
type Ia endoleaks Following teVaR  
for aortic Dissection
The etiology and pathology of aortic dissection is distinct from 
aortic aneurysms. Type Ia endoleak following TEVAR for thoracic 
aortic aneurysms is considered a procedure failure, and aggressive 
treatment is recommended to eliminate the leakage. On the other 
hand, a type Ia endoleak after TEVAR for the treatment of aortic 
dissection does not result in systemic pressurization of the cul-de 
sac and might not place the patient at the risk of rupture (3). Type 
Ia endoleak may result from the angulation or tortuosity of the 
aortic arch, and a short proximal landing zone and its immediate 
appearance seems to be an indication of worse aortic condition 
4Azevedo et al. Persistent Type I Endoleak
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(3). One of the main issues in addressing aortic arch pathologies 
is the short proximal landing zone, since an adequate length has 
to be present to ensure successful proximal fixation (4). Chimney 
technique, also described as periscope grafts technique, involves 
the placement of stents in side branches of aorta alongside the main 
endovascular stent graft and has shown to be a viable option in 
the treatment of thoracoabdominal aortic aneurysms and in aortic 
arch pathology, but its use in the treatment of type Ia endoleaks 
following TEVAR for aortic dissection is still limited (5, 6).
treatment options
The presence of an endoleak following TEVAR for the treatment 
of type B aortic dissection may not adversely impact technical 
success and short-term outcomes, as opposed to the treatment 
of aortic aneurysms. In fact, hemodynamic changes in the aorta 
may result in the sealing of the entry site and filling of the space 
with thrombotic material, resulting in the spontaneous disap-
pearance of the endoleak. However, the immediate appearance of 
an endoleak seems to point to a worse aortic condition and less 
likelihood of spontaneous resolution (3).
Several endovascular treatment options for type Ia endoleaks 
have been applied, mainly after (T)EVAR for thoracic or abdomi-
nal aortic aneurysm repair.
Insertion of an aortic cuff to extend endograft coverage more 
proximally or the placement of a large-caliber balloon expand-
able stent inside the proximal endograft to promote the seal 
is one of the treatment options available. As type Ia endoleaks 
frequently result from an angulated and tortuous aortic arch and 
short proximal landing zones, this treatment option may not be 
sufficient to promote the seal.
The use of customized fenestrated or branched endografts has 
shown promising results in aortic arch aneurysms. However, they 
are complex, technically challenging, and expensive procedures, 
and the material may not be immediately available for urgent 
procedures.
The Chimney (landing zones 1 and 2) or the sandwich tech-
nique (landing zone 0), in which standard aortic endografts and 
simultaneous branch vessel stenting are used, are increasingly 
more common alternative procedures for the treatment of aortic 
pathology extending to the aortic arch, including aortic dissec-
tion, aneurysm, rupture, or proximal endoleaks. The advantages 
of this technique include readily available (“on-the-shelf ”) stents, 
placed in aortic side branches, creating a prolonged proximal 
aortic landing zone without compromising the perfusion of the 
branches (7, 8). In the initial approach of this patient, although we 
recognized there was a short proximal landing zone, we consid-
ered that performing a TEVAR with planned left subclavian artery 
coverage would be a more simple procedure and sufficient to seal 
the proximal entry site. As the endoleak appeared, Chimney 
technique was later used to try to resolve it, by achieving proximal 
coverage.
Another treatment option available for patients not eligible for 
these interventions due to severe comorbidities or anatomical fac-
tors is transcatheter embolization of the leak. Previous published 
experiences include endoleak embolization using coils, cyanoacr-
ylate, and Onyx™, a relatively novel liquid embolic agent, most 
commonly used to treat intracranial arteriovenous malformations 
(9–11). A recent fixation system (Heli-FX EndoAnchor System, 
Aptus Endosystems, Sunnyvale, CA, USA) has successfully 
resolve type Ia endoleaks and endograft migration in patients 
with thoracic or abdominal aortic aneurysms that underwent (T)
EVAR (12). There is still limited published experience of type I 
endoleaks embolization, and the vast majority of the cases are 
of endoleaks following endovascular treatment of thoracic and 
abdominal aortic aneurysms and not aortic dissections.
The option of conventional open surgery allows easy access the 
site of the endoleak but carries particular high risk in middle- and 
old-aged, frail patients, with several comorbidities, who represent 
the majority of the population with aortic disease.
We decided to use the Chimney technique because of our 
previous experience with this procedure and local availability of 
material. At short- and mid-term follow-up, patency of the stents 
was preserved, but there was only a small decrease in the size of 
the endoleak. In future cases, a strategy of “watchful waiting” is to 
be considered, because long-term outcomes of the persistent type 
Ia endoleak in a dissected aorta remain undefined. If a treatment 
option is to be chosen, the use of a fenestrated prosthesis could 
be advantageous. The success of this technique in the treatment 
of type Ia endoleaks after TEVAR for aortic aneurysms has been 
described as reasonable, with no secondary rupture and high 
target vessel patency (5). However, its results in the treatment of 
type Ia endoleak following TEVAR for aortic dissection repair 
are sparse. In either case, long-term clinical and CT follow-up 
remain essential.
CoNCLUDING ReMaRKs
Type Ia endoleak is a known and common complication of 
endovascular treatment of type B aortic dissection. Chimney 
technique represents a treatment option in patients with type Ia 
endoleak at the level of the aortic arch, but despite the efforts 
undertaken to treat it, technical success can be difficult to achieve. 
Although the type Ia endoleak persisted, the patient remained 
clinically stable. Therefore, although the intervention was techni-
cally unsuccessful, there was a clinical improvement.
In future similar cases, the risk of a persistent endoleak must 
be taken into account by the Heart Team when selecting the 
most appropriate treatment strategy. Furthermore, the patient 
should be fully informed about the possible complications of the 
procedure and involved in the treatment decision.
Clinical and imagological (angioCT) follow-up are mandatory, 
although the clinical significance and prognostic implications of a 
persistent type Ia endoleak following endovascular treatment of 
aortic dissection remain poorly defined. In future research, clini-
cal and technical determinants of the need of type Ia endoleak 
closure and the best treatment option need to be addressed.
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